Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,922.00    -720.00 (-15.51%)
Bid:
3,922.00
Ask:
3,926.00
Spread: 4.00 (0.102%)
Market Cap: £14.81b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

8 Feb 2007 10:56

Halma PLC08 February 2007 Halma p.l.c. ('Halma') ACQUISITION OF LABSPHERE, INC Halma, the leading safety, health and sensor technology group, announces thecompletion on 7 February 2007 of the acquisition of Labsphere, Inc ('Labsphere')from X-Rite, Inc for an initial cash consideration of $13.9 million (£7.0million) and deferred cash consideration of $1.5 million (£0.8 million) pendingthe finalisation of the completion accounts. If the completion accounts to 31December 2006 demonstrate net tangible assets below $8 million (£4.1 million),the deferred consideration is adjustable $1 for $1. Unaudited accounts for the calendar year 2006 show revenues of $12.5 million(£6.3 million) and operating profit of $2.4 million (£1.2 million). The acquisition, which is immediately earnings enhancing, has been funded fromHalma's existing cash and debt facilities. Labsphere, based in North Sutton, New Hampshire, USA, is a world leader in thedesign and manufacture of innovative light testing and measurement products andspecialised optical coatings. These high quality devices and materials are usedby a wide range of end users, including government and commercial organisationsfor testing, measuring and calibrating optoelectronic devices against widelyaccepted National Standards of performance, to conform with regulations or drivetechnical advances. Andrew Williams, Halma's Chief Executive, commented, "Labsphere enhances Halma'spresence in the growing photonics market and complements our existing businesseswhere technical and marketing collaboration opportunities exist. Together withOcean Optics, Halma now has two leading companies in this exciting market wherewe are well placed to grow organically and through further acquisitions." For further information please contact: Halma p.l.c. +44 (0)1494 721111 Andrew Williams, Chief Executive Kevin Thompson, Finance Director Hogarth Partnership Limited +44 (0)20 7357 9477 Rachel Hirst/Andrew Jaques Notes 1. A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com. 2. This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma. 3. Exchange rate used: $1.97/£1. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.